Radiotherapy decisions should be made using refined genomic guidance, as recommended by 2021 updated international guidelines ...
Pesticides have gained negative attention in recent years owing to their links to biodiversity loss. But could pesticides ...
Despite everything I’ve been through, I’ve been really lucky. I went to the doctor assuming I wouldn’t get an answer, ...
BOSTON - A new study finds that people with breast cancer are more likely to develop a second cancer over time.
Survivors of breast cancer are at significantly higher risk of developing second cancers, including endometrial and ovarian ...
As for other tumor types, female breast cancer survivors were found to have an 87% higher odds of developing endometrial ...
People lucky enough to survive a breast cancer may still face heightened risks for other cancers later, a new study ...
The FDA accepted the supplemental biologics license for dostarlimab plus standard-of-care chemotherapy for all patients with ...
People with breast cancer are also found to be at higher risk for developing cancer in unaffected breast tissue, plus ovarian cancer and a form of leukemia. Also in the news: high levels of food ...
Drugmaker GSK said on Wednesday that the US Food and Drug Administration has accepted a supplemental Biologics License ...
Olivia Munn is in medically induced menopause as a result of treatment to keep her breast cancer from recurring, the actress ...
The US Food and Drug Administration accepted the supplemental Biologics License Application or sBLA for Jemperli (dostarlimab) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback